Cart
sales@molnova.com
Mafenide Acetate
CAS No. 13009-99-9
Mafenide Acetate ( —— )
Catalog No. M21177 CAS No. 13009-99-9
Mafenide Acetate is a sulfonamide-type medication??inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 43 | Get Quote |
|
| 100MG | 61 | Get Quote |
|
| 200MG | 82 | Get Quote |
|
| 500MG | 117 | Get Quote |
|
| 1G | 161 | Get Quote |
|
Biological Information
-
Product NameMafenide Acetate
-
NoteResearch use only not for human use.
-
Brief DescriptionMafenide Acetate is a sulfonamide-type medication??inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.
-
DescriptionMafenide Acetate is a sulfonamide-type medication??inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
IndicationBurnsSkin Burn Requiring Skin Graft
Chemical Information
-
CAS Number13009-99-9
-
Formula Weight246.29
-
Molecular FormulaC9H14N2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:35 mg/mL (142.11 mM)
-
SMILESCC(=O)O.NCc1ccc(S(N)(=O)=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Haynes B.W. Jr. Mafenide acetate in burn treatment. N Engl J Med 1971. 284(23): p. 1324.
molnova catalog
related products
-
Dabcyl acid, SE
Dabcyl acid, SE is the amino-reactive form of Dabcyl acid and used to prepare a variety of FRET-based probes that contain Dabcyl acid.
-
TT01001
TT01001 is a selective agonist of mitoNEET and reduces oxidative stress injury and neuronal apoptosis by improving mitochondrial dysfunction. TT01001 can be used in studies about the treatment of type II diabetes.
-
Quercetin 3-O-neohes...
Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.
